TechRxiv

Researchers conduct a study on a new COVID-19 variant.

They prepare a manuscript detailing their findings.

They submit the manuscript to TechRxiv.

TechRxiv screens the submission.

The preprint is published and made available to the global research community.

Other researchers access and build upon the findings.

Researchers complete a phase 1 clinical trial.

They prepare a manuscript summarizing the preliminary results.

They submit the manuscript to TechRxiv.

TechRxiv screens the submission.

The preprint is published.

Clinicians and other researchers use the data to inform treatment decisions and future trials.

Researchers develop a novel research methodology.

They prepare a manuscript describing the methodology and its applications.

They submit the manuscript to TechRxiv.

TechRxiv screens the submission.

The preprint is published.

Other researchers provide feedback and suggestions, improving the methodology.

Researchers make a significant discovery.

They prepare a manuscript detailing the discovery.

They submit the manuscript to TechRxiv.

TechRxiv screens the submission.

The preprint is published, establishing priority.

The researchers subsequently submit the manuscript for peer review and publication in a journal.

Researchers in a resource-limited setting conduct a study.

They prepare a manuscript describing their findings.

They submit the manuscript to TechRxiv.

TechRxiv screens the submission.

The preprint is published and made available to the global research community.

The research receives increased attention and support.